Read the latest positive news, breakthroughs, and inspiring stories about vaccine, curated daily by BrightWire.
The Democratic Republic of Congo is receiving 70,000 doses of proven Ebola vaccine as the world rallies to help fight the outbreak. With $13 million in funding and expanded treatment capacity, health teams are turning the tide on the epidemic.
The FDA just greenlit both a new drug and a new vaccine, marking a milestone week for medical innovation. These back-to-back approvals give patients more options and show the pace of scientific progress.
An FDA advisory committee unanimously recommended approval for the first mRNA flu vaccine, marking a major breakthrough that could save thousands of lives and make flu shots faster to produce. The same technology that powered COVID vaccines is now set to revolutionize flu prevention.
A 1920s tuberculosis vaccine is helping people with autoimmune diabetes reduce their insulin use in a breakthrough trial. The discovery adds to growing evidence that certain vaccines protect against diseases far beyond their original targets.
Scientists at Cambridge University have created the first vaccine designed entirely by artificial intelligence, and it just passed its first human trial. The breakthrough could protect us from future pandemics before they start.
A promising new Lyme disease vaccine from Pfizer and Valneva could protect against nearly half a million annual U.S. infections. The shot targets bacteria inside ticks before they can infect people.
Scientists at Johns Hopkins developed a nose-delivered vaccine that helps the body fight tuberculosis, the world's deadliest infectious disease. Early tests show it could shorten treatment times and prevent drug-resistant strains.
Pfizer and Valneva's experimental Lyme disease vaccine proved highly effective in Phase III trials, bringing hope to millions who love the outdoors. If approved, it would be the first Lyme vaccine available in two decades.
A new Lyme disease vaccine from Pfizer has shown 70% effectiveness in clinical trials, offering hope for protection against the tick-borne illness that affects hundreds of thousands annually. This marks the first promising Lyme vaccine in over two decades.
A groundbreaking breast cancer vaccine has received patent approval in South Korea, marking a major step toward preventing the world's most common cancer in women. The vaccine showed promising safety results and immune responses in 74% of trial participants.
Scientists at the University of Guelph have successfully tested the world's first vaccine against Campylobacter jejuni, a bacterial infection that causes millions of cases of severe diarrhea worldwide each year. The Phase 1 trial showed the vaccine is safe and triggers strong immune responses at even low doses.
Getting a shingles shot might do more than prevent a painful rash. New research shows it could actually slow down how fast your body ages.